Firazyr

Product NDC: 54092-702
11-digit product format: 540920702
Labeler code: 54092
Product ID: 54092-702_19b83a10-9f38-4d0d-ae46-0f5b28168873
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: icatibant acetate
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Labeler: Takeda Pharmaceuticals America, Inc.
Application: NDA022150
Marketing category: NDA
Marketing start: 2011-08-25
Substance: ICATIBANT ACETATE
Active strength: 30 mg/3mL
Pharmacologic classes: Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022150-001	FIRAZYR	ICATIBANT ACETATE	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N022150-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS		RLD, RS	2011-08-25	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022150-001	FIRAZYR	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	2011-08-25	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N022150-001	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022150-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022150-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022150-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022150-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022150-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022150-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022150-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022150-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022150-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022150-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022150-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022150-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022150-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022150-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022150-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022150-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022150-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022150-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022150-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022150-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022150-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022150-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022150-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022150-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022150-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022150-001	AP	1	`b00525d2431f…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022150-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022150-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022150-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022150-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022150-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022150-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022150-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022150-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022150-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022150-001	AP	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022150-001	AP	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022150-001	AP	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N022150-001	AP	1	`cb3db0bc1861…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N022150-001	5648333	2019-07-15	U-1187	Drug substance, Drug product	2011-09-22	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	N022150-001	5648333	2019-07-15	U-1187	Drug substance, Drug product	2011-09-22	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022150-001	5648333	2019-07-15	U-1187	Drug substance, Drug product	2011-09-22	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022150-001	5648333	2019-07-15	U-1187	Drug substance, Drug product	2011-09-22	`ea99ee380514…`

Additional Listing Data#

Finished product: Yes
Brand name base: Firazyr
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ICATIBANT ACETATE	30 mg/3mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
325O8467XK	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1148141	Internal RxNorm lookup
1148145	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
ed6657ca-ab68-477a-9968-e12dc928b540	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
94785027-dc4b-8998-43d4-c818590b3995	Product name	6	20241008
48747306-602a-42cc-957b-5b0c69158eee	Product name	1	20180604
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
54092-702-01	Firazyr	3 mL in 1 SYRINGE, GLASS	INJECTION, SOLUTION	3	19
54092-702-01	Firazyr	1 in 1 CARTON	INJECTION, SOLUTION	1	19
54092-702-02	Firazyr	3 mL in 1 SYRINGE, GLASS	INJECTION, SOLUTION	3	19
54092-702-02	Firazyr	1 in 1 CARTON	INJECTION, SOLUTION	1	19
54092-702-03	Firazyr	3 mL in 1 SYRINGE, GLASS	INJECTION, SOLUTION	3	19
54092-702-03	Firazyr	3 in 1 CARTON	INJECTION, SOLUTION	3	19

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
54092-702-02	ML - Milliliter	54092-702	054deaeb-401e-445e-a503-c80f61cd377a	1	2012-07-24
54092-702-03	ML - Milliliter	54092-702	9a9a11e1-82a6-41e2-99a9-2c5c9b177169	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
icatibant acetate	ACTIVE INGREDIENT	325O8467XK	FIRAZYR (ICATIBANT ACETATE) INJECTION, SOLUTION [SHIRE US MANUFACTURING INC.]	9
icatibant	ACTIVE MOIETY	7PG89G35Q7	FIRAZYR (ICATIBANT ACETATE) INJECTION, SOLUTION [SHIRE US MANUFACTURING INC.]	9
acetic acid	INACTIVE INGREDIENT	Q40Q9N063P	FIRAZYR (ICATIBANT ACETATE) INJECTION, SOLUTION [SHIRE US MANUFACTURING INC.]	9
sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	FIRAZYR (ICATIBANT ACETATE) INJECTION, SOLUTION [SHIRE US MANUFACTURING INC.]	9
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	FIRAZYR (ICATIBANT ACETATE) INJECTION, SOLUTION [SHIRE US MANUFACTURING INC.]	9
water	INACTIVE INGREDIENT	059QF0KO0R	FIRAZYR (ICATIBANT ACETATE) INJECTION, SOLUTION [SHIRE US MANUFACTURING INC.]	9

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
54092-702	FIRAZYR (ICATIBANT ACETATE) INJECTION, SOLUTION [TAKEDA PHARMACEUTICALS AMERICA, INC.]	18	Current NDC, Legacy NDC, 6 package rows	20240131_ed6657ca-ab68-477a-9968-e12dc928b540.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Firazyr	ICATIBANT ACETATE	Takeda Pharmaceuticals America, Inc.	ed6657ca-ab68-477a-9968-e12dc928b540	2025-07-07	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022150 application number: NDA022150 ndc (product): 54092-702

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
325O8467XK	ICATIBANT ACETATE	138614-30-9	ICATIBANT ACETATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1148145	firazyr 30 MG in 3 ML Prefilled Syringe	PSN	ed6657ca-ab68-477a-9968-e12dc928b540	19
1148141	icatibant 30 MG in 3 ML Prefilled Syringe	PSN	ed6657ca-ab68-477a-9968-e12dc928b540	19
1148145	3 ML icatibant 10 MG/ML Prefilled Syringe [Firazyr]	SBD	ed6657ca-ab68-477a-9968-e12dc928b540	19
1148141	3 ML icatibant 10 MG/ML Prefilled Syringe	SCD	ed6657ca-ab68-477a-9968-e12dc928b540	19
1148145	3 ML Firazyr 10 MG/ML (as icatibant acetate) Prefilled Syringe	SY	ed6657ca-ab68-477a-9968-e12dc928b540	19
1148145	3 ML Firazyr 10 MG/ML Prefilled Syringe	SY	ed6657ca-ab68-477a-9968-e12dc928b540	19
1148145	Firazyr 30 MG per 3 ML Prefilled Syringe	SY	ed6657ca-ab68-477a-9968-e12dc928b540	19
1148141	icatibant (as icatibant acetate) 30 MG per 3 ML Prefilled Syringe	SY	ed6657ca-ab68-477a-9968-e12dc928b540	19

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
54092-702-01	54092070201	1 SYRINGE, GLASS in 1 CARTON (54092-702-01) / 3 mL in 1 SYRINGE, GLASS	2011-08-25	0000-00-00	No	No	Current
54092-702-02	54092070202	1 SYRINGE, GLASS in 1 CARTON (54092-702-02) / 3 mL in 1 SYRINGE, GLASS	2011-08-25	0000-00-00	No	No	Current
54092-702-03	54092070203	3 SYRINGE, GLASS in 1 CARTON (54092-702-03) / 3 mL in 1 SYRINGE, GLASS	2011-08-25	0000-00-00	No	No	Current